Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation

Starting soon

Conditions studied: Chronic Pain, Ketamine

In brief

Ketamine is an anesthetic drug that is sometimes used to relieve chronic pain. The goal of this observational study is to learn about how patients respond to ketamine infusions for chronic pain. Note: This study does not provide ketamine - instead, this study uses surveys to follow patients who are already scheduled to receive ketamine infusions as part of their regular medical care. We will also follow a second group of patients who were recommended ketamine infusions by their doctor but were denied insurance coverage for this treatment. These participants will complete the same surveys for up to 16 weeks, starting from when their treatment was originally scheduled. Comparing this group to patients who received ketamine will help researchers better understand ketamine's effects and how insurance denials affect chronic pain patients.

Key facts

Study ID

NCT07648771

Run by

Stanford University

People needed

800

Starts

2026-08-01

Expected to finish

2034-12-01

Last updated by the study team

2026-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planning to receive an intravenous ketamine infusion for the treatment of chronic pain

You may not qualify if…

• Unable to read or understand English questionnaires

Where it is running

• Stanford Health Care — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.